Try our Advanced Search for more refined results
Health - December, 2005
30 articles
- McKesson Settles Derivative Suit For $30M
- Ranbaxy Abandons Bid For Early Generic Provigil
- Ex-HealthSouth Exec Gets One Year In Fraud Case
- Celebrity Doctor Prevails In Skin Care Case
- Tiny Biotech Company Wins $48M Trade Secret Award
- ITC To Probe Medical Device Patent Infringement Claims
- Mylan's Levaquin Appeal Shot Down By Federal Circuit
- Mylan, J&J In Authorized Generics Deal Over Ditropan XL
- Lipitor Case Proves Strength Of Molecular Patents
- Andrx, Glaxo In New Row Over Wellbutrin
- Judge Triples Damages To $15.9M In Third Wave Suit
- $213.9M Verdict Upheld In Advanced Medical Optics Case
- Pfizer Wins Lipitor Patent Challenge
- Former WebMD Execs Indicted For Fraud
- Applera & Bio-Rad In Settlement Talks Over PCR
- J&J Cries Trademark Breach Over Reprocessed Devices
- Mylan Pharma Takes On Boehringer's Mirapex Patent
- Victory For Takeda Abbott In Prostate Drug Patent Suit
- Boston Scientific Asserts Stent Patents In Netherlands
- Genetic Technologies, Applera Settle DNA Analysis Row
- Cephalon, Teva Settle Patent Dispute Over Provigil
- Former Bon Secours CFO Admits To $117M Fraud
- Bill Could Trigger Wave Of Process Patent Suits
- Eisai Sues Teva Over ANDA For Alzheimer's Drug
- Bally Must Turn Over Board Minutes To Investor
- U.S. Welcomes New WTO Compulsory Licensing Policy
- J&J Medical Device Prevails In Trade Secret Appeal
- Abbott Labs Sued By Activists Over AIDS Drug Patents
- Barr, Organon Pen Mircette "Authorized Generic" Deal
- E.U. OKs Compulsory Licensing For Drug Exports